These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2564435)

  • 41. Drug therapy in schizophrenia--variability of outcome and prediction of response.
    Awad AG
    Can J Psychiatry; 1989 Oct; 34(7):711-20. PubMed ID: 2572318
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The volume of the mediodorsal thalamic nucleus in treated and untreated schizophrenics.
    Pakkenberg B
    Schizophr Res; 1992 Jul; 7(2):95-100. PubMed ID: 1355358
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of neuroleptics on positive and negative symptoms and the deficit state.
    Angst J; Stassen HH; Woggon B
    Psychopharmacology (Berl); 1989; 99 Suppl():S41-6. PubMed ID: 2573105
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of neuroleptic treatment on positive and negative symptoms of schizophrenia and the results of the dexamethasone test].
    Rybakowski J; Linka M
    Psychiatr Pol; 1991; 25(1):1-6. PubMed ID: 1685787
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Episodic and residual thought pathology in chronic schizophrenics: effect of neuroleptics.
    Spohn HE; Coyne L; Larson J; Mittleman F; Spray J; Hayes K
    Schizophr Bull; 1986; 12(3):394-407. PubMed ID: 2876514
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The relationship of symptomatology and medication to electrodermal activity in schizophrenia.
    Green MF; Nuechterlein KH; Satz P
    Psychophysiology; 1989 Mar; 26(2):148-57. PubMed ID: 2567035
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Benzodiazepines in the treatment of schizophrenia: an updated survey.
    Lingjaerde O
    Acta Psychiatr Scand; 1991 Nov; 84(5):453-9. PubMed ID: 1685616
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gender and the use of neuroleptics in schizophrenia. Further testing of the oestrogen hypothesis.
    Salokangas RK
    Schizophr Res; 1995 Jul; 16(1):7-16. PubMed ID: 7547647
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Commentary on: "Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia." Psychopharmacology (1980) 72:17-19.
    Angrist B; Rotrosen J; Gershon S
    Psychopharmacology (Berl); 2001 Nov; 158(3):219-21. PubMed ID: 11713609
    [No Abstract]   [Full Text] [Related]  

  • 50. Combined alprazolam and neuroleptic drug in treating schizophrenia.
    Bacher NM; Lewis HA; Field PB
    Am J Psychiatry; 1986 Oct; 143(10):1311-3. PubMed ID: 2876649
    [No Abstract]   [Full Text] [Related]  

  • 51. Genetic factors in the response to neuroleptics in schizophrenia: a psychopharmacogenetic study.
    Galdi J; Rieder RO; Silber D; Bonato RR
    Psychol Med; 1981 Nov; 11(4):713-28. PubMed ID: 6119718
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Continuous versus intermittent neuroleptic therapy in schizophrenia.
    Jolley AG; Hirsch SR
    Drug Saf; 1993 May; 8(5):331-9. PubMed ID: 8099290
    [No Abstract]   [Full Text] [Related]  

  • 53. Neuroleptic depression in schizophrenia.
    Harrow M; Fichtner CG; Grossman LS; Yonan CA; Sands J
    Biol Psychiatry; 1991 Oct; 30(8):845-8. PubMed ID: 1684298
    [No Abstract]   [Full Text] [Related]  

  • 54. The effects of antipsychotic medication on the linguistic ability of schizophrenics.
    Hymowitz P; Spohn H
    J Nerv Ment Dis; 1980 May; 168(5):287-96. PubMed ID: 6102593
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Medication, logic, and schizophernic thinking: a reply to Marini.
    Ho DY
    J Genet Psychol; 1976 Sep; 129(1st Half):93-5. PubMed ID: 9471
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Benefits of correlating neuroleptic blood level and auditory distractibility.
    Terkelsen KG
    Am J Psychiatry; 1985 Dec; 142(12):1523-4. PubMed ID: 2866721
    [No Abstract]   [Full Text] [Related]  

  • 57. Abnormal EEG patterns in treatment-resistant schizophrenic patients.
    Ramos J; Cerdán LF; Guevara MA; Amezcua C; Sanz A
    Int J Neurosci; 2001 Jul; 109(1-2):47-59. PubMed ID: 11699340
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term 'treatment' of schizophrenics with typical neuroleptics: a crime against humanity?
    Elomaa E
    Med Hypotheses; 1993 Nov; 41(5):434. PubMed ID: 7908399
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Schizophrenics fully remitted on neuroleptics for 3-5 years--to stop or continue drugs?
    Cheung HK
    Br J Psychiatry; 1981 Jun; 138():490-4. PubMed ID: 6117347
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Computerized EEG as a predictor of drug response in treatment resistant schizophrenics.
    Itil TM; Shapiro D; Schneider SJ; Francis IB
    J Nerv Ment Dis; 1981 Oct; 169(10):629-37. PubMed ID: 6116742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.